Every issue raised by the current investigation into the business prac
tices of Columbia/HCA serves as a sign post for the progress and probl
ems inherent in market-driven health care reform. Actions against Colu
mbia/HCA by regulators reveal deeply rooted resistance to the profit-m
otivated reforms embodied in the company's philosophy: the public's re
luctance to accept necessary reductions in excess hospital capacity; t
he legal and cultural obstacles to the overdue alignment of physician
and hospital economic interests; and the myriad reimbursement and acco
unting problems involved in the vertical integration of health care de
livery. The investigation also underscores the antiquation of the reim
bursement mechanisms and control systems in place for financing the de
livery of care to Medicare beneficiaries.